Cellebrite DI Ltd (NASDAQ:CLBT) price on current trading day, rose 1.78% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $15.47.
A look at the stock’s price movement, the level at last check in today’s session was $15.2, moving within a range at $15.075 and $15.63. The beta value (5-Year monthly) was 1.321. Turning to its 52-week performance, $26.30 and $11.47 were the 52-week high and 52-week low respectively. Overall, CLBT moved -7.14% over the past month.
Cellebrite DI Ltd’s market cap currently stands at around $3.70 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-14.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CLBT is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
6 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 6 recommend CLBT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CLBT’s current price about -3.51% and -11.15% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 37.70, while 7-day volatility ratio is 3.26% and 3.24% in the 30-day chart. Further, Cellebrite DI Ltd (CLBT) has a beta value of 1.29. Analysts have given the company’s stock an average 52-week price target of $20, forecast between a low of $17 and high of $23. Looking at the price targets, the low is -9.89% off recent price level in today’s trading while to achieve the yearly target high, it has to move -48.67%. Nonetheless, investors will most likely welcome a -29.28% jump to $20 which is the analysts’ median price.
If we refocus on Cellebrite DI Ltd (NASDAQ:CLBT), historical trading data shows that trading volumes averaged 1.54 over the past 10 days and 1.31 million over the past 3 months. The company’s latest data on shares outstanding shows there are 239.47 million shares.
The 54.50% of Cellebrite DI Ltd’s shares are in the hands of company insiders while institutional holders own 37.05% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.19 million on 2025-06-13, giving us a short ratio of 0.72. The data shows that as of 2025-06-13 short interest in Cellebrite DI Ltd (CLBT) stood at 102.99999 of shares outstanding, with shares short falling to 1.81 million registered in 2025-05-15. Current price change has pushed the stock 27.43% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CLBT stock continues to rise going into the next quarter.
